Dynamk Capital is focused on partnering with Life Sciences companies to accelerate their growth and technology adoption of disruptive solutions and services.  Our portfolio companies innovate the tools, technologies and services that enable the discovery, development and production of life-saving therapies and deliver on the biopharmaceutical industry's evolution towards lower costs, and increased access to medicines globally. 

We are passionate about accelerating the growth of our portfolio businesses. 

 

Our team >

We understand entrepreneurs because we are entrepreneurs. We focus on underserved segments of capital markets, providing B2B tools and services companies in Life Sciences with unique perspective in strategy, operations, business development and commercialization to accelerate their growth.